Khan Ahsan Yaqoob, Shaikh Mohammad Rafique, Ablah Elizabeth
Department of Psychiatry & Behavioral Health, University of Kansas School of Medicine, Wichita, USA.
J Pak Med Assoc. 2010 Jun;60(6):446-50.
To examine the extent of compliance to the proposed monitoring protocol among practicing psychiatrists for second generation antipsychotics.
Questionnaire was sent through Survey Monkey to practicing psychiatrists in the states of Iowa, Kansas, Missouri, Nebraska, Oklahoma and Texas. Also paper surveys were distributed to individual psychiatrists of Kansas and Nebraska at their grand rounds, inpatient settings, and outpatient clinics.
Ninety eight responses were received of which 51 participants completed the survey on Survey Monkey and 47 completed the paper surveys. Fifty-one percent reported that 25% to 50% of their patients were taking SGAs. About two thirds (69.4%) reported familiarity with the proposed protocol, 17.3% were unfamiliar, and 13% were not sure. Of those who were familiar, 63% percent reported their adherence to the protocol, 21% did not follow the protocol, and 16% were not sure. However, when their responses were closely examined, only five (5%) of the respondents were found completely adherent to the protocol.
Majority of participants were aware of the proposed protocol to protect their patients from metabolic side effects but many of them did not follow it completely. A large study at the national level needs to be done to replicate these findings.
调查执业精神科医生对第二代抗精神病药物拟议监测方案的遵守程度。
通过Survey Monkey向爱荷华州、堪萨斯州、密苏里州、内布拉斯加州、俄克拉何马州和得克萨斯州的执业精神科医生发送问卷。同时，在堪萨斯州和内布拉斯加州的学术大查房、住院部和门诊诊所向精神科医生个人发放纸质调查问卷。
共收到98份回复，其中51名参与者在Survey Monkey上完成了调查，47名完成了纸质调查问卷。51%的人报告称其25%至50%的患者正在服用第二代抗精神病药物。约三分之二（69.4%）的人报告熟悉拟议方案，17.3%不熟悉，13%不确定。在熟悉方案的人中，63%报告遵守该方案，21%未遵守，16%不确定。然而，仔细检查他们的回复后发现，只有5名（5%）受访者完全遵守该方案。
大多数参与者知晓拟议的保护患者免受代谢副作用影响的方案，但其中许多人并未完全遵守。需要在全国范围内开展大规模研究以重现这些发现。
